'Walking Meetings' Feasible Strategy for Employee Wellness

Share this content:
'Walking Meetings' Feasible Strategy for Employee Wellness
'Walking Meetings' Feasible Strategy for Employee Wellness

MONDAY, July 25, 2016 (HealthDay News) -- Converting a single weekly meeting to a walking meeting can help raise work-related physical activity levels of white-collar workers, according to a report published online June 23 in the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease.

The researchers analyzed data on 17 white-collar workers recruited from the University of Miami. The employees had meetings once a week in groups of two or three. Over a three-week period, participants wore accelerometers during the workday. During the first week, the workers went about their normal activities, without a walking meeting. Over the second and third weeks, however, they had one weekly walking meeting lasting 30 minutes.

The researchers found that participants increased their moderate/vigorous physical activity from 107 minutes in the first week to 114 minutes in the second week and then to 117 minutes in the third week.

"Taken together, the study enrollment, response rate (94 percent), and completion of walking meetings (88 percent) suggest that walking meetings were feasible for this sample of white-collar workers," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »